(marketscreener.com) Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC are investigating the proposed merger of Homology Medicines, Inc. with Q32 Bio Inc. Under the terms of the proposed transaction, Homology shareholders will end up owning approximately 25% of the combined company, subject to possible...https://www.marketscreener.com/quote/stock/HOMOLOGY-MEDICINES-INC-42529124/news/HOMOLOGY-MEDICINES-INVESTOR-ALERT-by-the-Former-Attorney-General-of-Louisiana-Kahn-Swick-Foti-LL-46042095/?utm_medium=RSS&utm_content=20240227
Homology is a Massachusetts-based clinical-stage genetic medicine company that develops and commercializes novel therapies for the treatment of genetic diseases.